The global obesity epidemic has paved the way for local scientists to drive a deal that could be worth hundreds of millions of dollars, and is potentially the richest of its type seen in Australia. Shares in Pharmaxis surged on Monday on news it has signed a deal with a global drugs major to pursue development of a compound developed by local scientists which has barely made it to the test tube.